July 2, 2026

Taiwan’s FDA has proposed putting Misoprostol and two emergency contraceptives, Levonorgestrel and Ulipristal Acetate, into a tighter tracking system after suspected illegal sales. Pharmacists warn the crackdown could choke access to emergency contraception, turning oversight into a fresh fight over reproductive medicine. Access on the line

Leave a Reply